Cargando…

PrabotulinumtoxinA for Treatment of Millennials With Moderate to Severe Glabellar Lines: Post Hoc Analyses of the Phase III Clinical Study Data

The use of esthetic products by millennials is increasing, yet published clinical trial data in this population are limited. OBJECTIVE: To compare the efficacy and safety of prabotulinumtoxinA for the treatment of moderate to severe glabellar lines in millennial and nonmillennial patients. METHODS A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogilvie, Patricia, Jones, Derek H., Avelar, Rui L., Jonker, Anneke, Monroe, Rose, Carruthers, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154296/ https://www.ncbi.nlm.nih.gov/pubmed/35616616 http://dx.doi.org/10.1097/DSS.0000000000003456

Ejemplares similares

PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data
por: Taylor, Susan C., et al.
Publicado: (2021)

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data
por: Solish, Nowell, et al.
Publicado: (2022)

Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies
por: Beer, Kenneth R., et al.
Publicado: (2019)

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Lorenc, Z Paul, et al.
Publicado: (2021)

Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Lorenc, Z Paul, et al.
Publicado: (2021)

A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA
por: Rupp, David C, et al.
Publicado: (2023)

Safety and Efficacy of PrabotulinumtoxinA (Nabota(®)) Injection for Cervical and Shoulder Girdle Myofascial Pain Syndrome: A Pilot Study
por: Kim, Da-ye, et al.
Publicado: (2018)

Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow’s Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
por: Lee, Soo-Kyung, et al.
Publicado: (2023)

Treatment of glabellar lines with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Carruthers, Jean, et al.
Publicado: (2023)

Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
por: Carruthers, Alastair, et al.
Publicado: (2016)

Angiomyolipoma of the Glabellar Region
por: Kim, Hyo Joong, et al.
Publicado: (2017)

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines
por: Humphrey, Shannon, et al.
Publicado: (2023)

Optimizing Outcomes When Treating Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2023)

Botulinum toxin type-A in the treatment of glabellar lines
por: Winter, Leslie, et al.
Publicado: (2009)

Integrative Assessment for Optimizing Aesthetic Outcomes When Treating Glabellar Lines With Botulinum Toxin Type A: An Appreciation of the Role of the Frontalis
por: Bertucci, Vince, et al.
Publicado: (2022)

Glabellar Presentation, Its Incidence and Termination
por: Mudaliar, A. L.
Publicado: (1934)

Glabellar flap technique in oculoplastic surgery
por: Balchev, Georgi, et al.
Publicado: (2022)

Glabellar and auricular leukemia cutis in CLL
por: Steinman, Bradley, et al.
Publicado: (2022)

The Crest Injection Technique for Glabellar Line Correction and the Paracentral Artery
por: Tansatit, Tanvaa, et al.
Publicado: (2021)

Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines
por: Yi, Kyu-Ho, et al.
Publicado: (2022)

The Millennial Myth
por: Kadakia, Crystal
Publicado: (2017)

Marketing to Millennials
por: Fromm, Jeff
Publicado: (2013)

Millennials with Kids
por: Fromm, Jeff
Publicado: (2015)

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
por: Dayan, Steven, et al.
Publicado: (2022)

Millennials in the Workplace: A Communication Perspective on Millennials’ Organizational Relationships and Performance
por: Myers, Karen K., et al.
Publicado: (2010)

Glabellar vertical line as a reference goal for anteroposterior maxillary position
por: Carruitero, Marcos J., et al.
Publicado: (2019)

Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation
por: Kim, Soo-Bin, et al.
Publicado: (2021)

Commentary: A technical revisit to the glabellar flap
por: Singh, Manpreet, et al.
Publicado: (2022)

Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study
por: Kestemont, Philippe, et al.
Publicado: (2021)

Millennial Money Makeover
por: Richardson, Conor
Publicado: (2019)

The Millennial Generation and “The Lecture”
por: Hart, Danielle, et al.
Publicado: (2011)

Managing Millennials For Dummies
por: Ubl, Hannah
Publicado: (2017)

Marketing to Millennials For Dummies
por: Padveen, Corey
Publicado: (2017)

Millennials and COVID-19
por: Hidalgo, Benjamin, et al.
Publicado: (2022)

Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
por: Prager, Welf
Publicado: (2013)

Slack It to Me: Complementing LMS With Student-Centric Communications for the Millennial/Post-Millennial Student
por: Ross, Spencer M.
Publicado: (2019)

Botulinum toxin type A for the management of glabellar rhytids
por: Tremaine, Anne Marie, et al.
Publicado: (2010)

Diagnostic accuracy of glabellar tap sign for Parkinson’s disease
por: Nuuttila, Simo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ts37tg7qjk1ecq6e01tms46bs4